Literature DB >> 9603951

Structure and expression of the orphan nuclear receptor SHP gene.

H K Lee1, Y K Lee, S H Park, Y S Kim, S H Park, J W Lee, H B Kwon, J Soh, D D Moore, H S Choi.   

Abstract

To determine the organization of the orphan nuclear receptor SHP gene (Seol, W., Choi, H.-S., and Moore, D.D. (1996) Science 272, 1336-1339), genomic clones were isolated from human and mouse genomic libraries. The SHP gene was composed of two exons interrupted by a single intron spanning approximately 1.8 kilobases in human and 1.2 kilobases in mouse. Genomic Southern blot analysis and fluorescence in situ hybridization of human metaphase chromosomes indicated that the SHP gene is located at the human chromosome 1p36.1 subband. The 5'-flanking regions of human and mouse SHP genes were highly conserved, showing 77% homology in the region of approximately 600 nucleotides upstream from the transcription start site. Primer extension analysis was carried out to determine the transcription start site of human SHP to 32 nucleotides downstream of a potential TATA box. The human SHP gene was specifically expressed in fetal liver, fetal adrenal gland, adult spleen, and adult small intestine. As expected from this expression pattern, the activity of the mouse SHP promoter measured by transient transfection was significantly higher in the adrenal-derived Y1 cells than HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603951     DOI: 10.1074/jbc.273.23.14398

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 2.  Role of nuclear receptor SHP in metabolism and cancer.

Authors:  Yuxia Zhang; Curt H Hagedorn; Li Wang
Journal:  Biochim Biophys Acta       Date:  2010-10-20

Review 3.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

4.  The farnesoid X receptor regulates transcription of 3beta-hydroxysteroid dehydrogenase type 2 in human adrenal cells.

Authors:  Yewei Xing; Karla Saner-Amigh; Yasuhiro Nakamura; Margaret M Hinshelwood; Bruce R Carr; J Ian Mason; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2008-11-18       Impact factor: 4.102

5.  Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis.

Authors:  Sayeepriyadarshini Anakk; Mitsuhiro Watanabe; Scott A Ochsner; Neil J McKenna; Milton J Finegold; David D Moore
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

6.  Insights into the binding mode and mechanism of action of some atypical retinoids as ligands of the small heterodimer partner (SHP).

Authors:  Marco Cellanetti; Viswanath Gunda; Li Wang; Antonio Macchiarulo; Roberto Pellicciari
Journal:  J Comput Aided Mol Des       Date:  2010-09-30       Impact factor: 3.686

Review 7.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02

8.  Role of an mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP.

Authors:  Jongsook Kim Kemper; Hwajin Kim; Ji Miao; Sonali Bhalla; Yangjin Bae
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 9.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

10.  Bile acids inhibit duodenal secretin expression via orphan nuclear receptor small heterodimer partner (SHP).

Authors:  Ian P Y Lam; Leo T O Lee; Hueng-Sik Choi; Gianfranco Alpini; Billy K C Chow
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-16       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.